Mci-186 → HCID 131729728, compound

Participants

Reaction Steps

80 mg of sodium ozagrel was dissolved in an adequate amount of an electrolyte solution or carbohydrate solution and the resulting solution was intravenously administered constantly for 2 weeks, twice daily, that is, in the morning and evening, each over 2 hours. At the same time, 30 mg/20 ml of edaravone was diluted with an adequate amount of physiological saline and the resulting solution was intravenously infused for 2 weeks, twice daily, that is, in the morning and evening, each over 20 minutes.

Provenance & Evidence